A powerful new chemotherapy drug with fewer side effects is being given to Australian cancer patients as part of a trial. Pharmaceutical
company Starpharma is trialling a new formula of the drug Docetaxel,
which is 40 times stronger than previous versions.
The drug is injected into the blood stream of patients undergoing breast, lung and prostate cancer treatment and is reportedly better at targeting cancer cells without having an impact on healthy tissue.
The drug is injected into the blood stream of patients undergoing breast, lung and prostate cancer treatment and is reportedly better at targeting cancer cells without having an impact on healthy tissue.
Starpharma CEO Dr Jackie Fairley said none of the patients undergoing the trial had experienced hair loss. "This
is an Australian innovation and Australian company, but even better
still Australian patients are getting access to this new therapy first,"
she said.
Dr Fairley said Starpharma is looking for patients with solid tissue tumors who have not responded to other therapies.
For more information on the chemotherapy trial call 1800 266 076.
For more information on the chemotherapy trial call 1800 266 076.
No comments:
Post a Comment